Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial (Q45114588)

9 December 2017

Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial (English)

1 reference

9 December 2017

congenital heart disease

1 reference

Zaccaria Ricci

1

1 reference

9 December 2017

Cristiana Garisto

2

1 reference

9 December 2017

Isabella Favia

3

1 reference

9 December 2017

Vincenzo Vitale

4

1 reference

9 December 2017

Luca Di Chiara

5

1 reference

9 December 2017

Paola E Cogo

6

1 reference

9 December 2017

18 April 2012

1 reference

9 December 2017

Intensive Care Medicine

1 reference

9 December 2017

38

1 reference

9 December 2017

7

1 reference

9 December 2017

1198-1204

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-012-2564-6

9 December 2017

0 references

cites work

Cardiovascular catecholamine receptors in children: their significance in cardiac disease

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Heart failure treatment in the intensive care unit in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Postoperative management in patients with complex congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Levosimendan: calcium sensitizer and inodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Levosimendan is a mitochondrial K(ATP) channel opener

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Consensus-based method for risk adjustment for surgery for congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

The Pediatric Multiple Organ Dysfunction Score (P-MODS): development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Blood lactate levels differ significantly between surviving and nonsurviving patients within the same risk-adjusted Classification for Congenital Heart Surgery (RACHS-1) group after pediatric cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2564-6

Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use

21 January 2018

1 reference

12 December 2020

Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.

1 reference

12 December 2020

Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure

1 reference

12 December 2020

Preconditioning effects of levosimendan in coronary artery bypass grafting—a pilot study

1 reference

12 December 2020

Early experience with Levosimendan in children with ventricular dysfunction

1 reference

12 December 2020

Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass

1 reference

12 December 2020

Mechanisms of action of calcium-sensitizing drugs

1 reference

12 December 2020

Inoprotection: the perioperative role of levosimendan.

1 reference

12 December 2020

10.1007/S00134-012-2564-6

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference